Open AccessClinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or without Bevacizumab
Author(s) -
M.J.M. Magbanua,
O. Savenkov,
E.J. Asmus,
K.V. Ballman,
J.H. Scott,
J.W. Park,
M. Dickler,
A. Partridge,
L.A. Carey,
E.P. Winer,
H.S. Rugo
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/db2c-g389
Subject(s) - letrozole , metastatic breast cancer , bevacizumab , medicine , breast cancer , oncology , circulating tumor cell , hormone receptor , cancer , metastasis , chemotherapy , aromatase